C07C 313/00
Sulfinic acids
Official title: Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
C07C313/00 (Sulfinic acids) appears on 310 US grants and 223 published applications in this corpus.
Search patents in C07C- Granted patents
- 310
- Published applications
- 223
- Assignees
- 169
- Inventors
- 827
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 7 | 0 |
| 1978 | 6 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 7 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 7 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 7 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 8 | 0 |
| 1998 | 6 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 11 | 1 |
| 2002 | 12 | 6 |
| 2003 | 6 | 11 |
| 2004 | 3 | 6 |
| 2005 | 6 | 9 |
| 2006 | 8 | 6 |
| 2007 | 5 | 6 |
| 2008 | 8 | 8 |
| 2009 | 4 | 8 |
| 2010 | 3 | 3 |
| 2011 | 3 | 11 |
| 2012 | 4 | 9 |
| 2013 | 6 | 9 |
| 2014 | 9 | 19 |
| 2015 | 16 | 12 |
| 2016 | 9 | 11 |
| 2017 | 12 | 12 |
| 2018 | 9 | 9 |
| 2019 | 5 | 9 |
| 2020 | 6 | 12 |
| 2021 | 6 | 7 |
| 2022 | 8 | 10 |
| 2023 | 4 | 8 |
| 2024 | 6 | 10 |
| 2025 | 9 | 7 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Synthesis of sulfonamide intermediates14 Oct 2025US 12,441,681 B2Amgen Inc.
- Phenylalanine-based LAT1 inhibitors and uses thereof30 Sep 2025US 12,427,124 B1Maxymune Therapeutics, Inc.
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds23 Sep 2025US 12,421,246 B2Eisai R&D Management Co., Ltd.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds14 May 2026US 2026/0132144 A1Eisai R&D Management Co., Ltd.
- Complexes and Compounds of Mercaptophenols and Curcumin for Therapeutic Applications23 Apr 2026US 2026/0109720 A1
- Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for producing electronic device1 Jan 2026US 2026/0003268 A1FUJIFILM Corporation
- Phenylalanine-based lat1 inhibitors and uses thereof6 Nov 2025US 2025/0339388 A1Maxymune Therapeutics, Inc.
Most cited
By later US patents
- Amino-benzocycloalkane derivatives63US 6,197,798 B1Novartis AG · 2001
- Heteroatom containing perfluoroalkyl terminated neopentyl glycols and compositions therefrom61US 4,946,992 ACiba-Geigy Corporation · 1990
- Heteroatom containing perfluoroalkyl terminated neopentyl glycols and compositions therefrom58US 4,898,981 ACiba-Geigy Corporation · 1990
- Amorphous tetrafluoroethylene-hexafluoropropylene copolymers54US 5,663,255 AE. I. Du Pont de Nemours and Company · 1997
- Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient54US 6,448,290 B1Ono Pharmaceutical Co., Ltd. · 2002